Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details

CellCarta (Group)

CellCarta is a leading provider of specialized precision medicine laboratory services to the biopharmaceutical industry. Leveraging its integrated analytical platforms in immunology, histopathology, proteomics and genomics, as well as related specimen collection and logistics services, CellCarta supports the entire drug development cycle, from discovery to late-stage clinical trials. The company operates globally with 10 facilities located in Canada, USA, Belgium, Australia, and China. *


Period Start 2021-01-26 renamed
Products Industry ImmuneCarta® flow cytometry services
  Industry 2 mass spectrometry services (MS services)
Person Person LeBlanc, Martin (Caprion Proteomics 201207 CEO)
Region Region Montréal, QC
  Country Canada
  City n. a. 
    Address record changed: 2021-12-15
Basic data Employees n. a.
    * Document for »About Section«: CellCarta. (12/14/21). "Press Release: CellCarta Acquires Biogazelle to Strengthen Its Genomic Capabilities and Expand into Digital PCR (dPCR) Services". Montréal.
Record changed: 2023-07-10


Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture Sino Biological Symposium Antibody Engineering Leipzig 650x200px

» top